The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen

  1. Lookup NU author(s)
  2. Elizabeth Sconce
  3. Dr Tayyaba Khan
  4. Dr Hilary Wynne
  5. Dr Peter Avery
  6. Dr Barry King
  7. Peter Wood
  8. Dr Patrick Kesteven
  9. Professor Ann Daly
  10. Professor Farhad Kamali
Author(s)Sconce EA, Khan TI, Wynne HA, Avery P, Monkhouse L, King BP, Wood P, Kesteven P, Daly AK, Kamali F
Publication type Article
JournalBlood
Year2005
Volume106
Issue7
Pages2329-2333
ISSN (print)0006-4971
ISSN (electronic)1528-0020
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherAmerican Society of Hematology
URLhttp://dx.doi.org/10.1182/blood-2005-03-1108
DOI10.1182/blood-2005-03-1108
PubMed id15947090
Actions    Link to this publication
Share